These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30695591)

  • 21. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
    Beauchesne P; Pedeux R; Boniol M; Soler C
    J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
    Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
    Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Low malignancy grade glioma in the Uppsala++/Orebro region. Prognostic factors and survival among 119 patients].
    Ribom D; Adner J; Eriksson A; Persson L; Smits A
    Lakartidningen; 2000 Sep; 97(36):3880-4. PubMed ID: 11036338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors in brainstem gliomas.
    Cohen ME; Duffner PK; Heffner RR; Lacey DJ; Brecher M
    Neurology; 1986 May; 36(5):602-5. PubMed ID: 3703258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
    Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of pediatric brain tumors.
    Packer RJ
    Curr Opin Neurol; 1994 Dec; 7(6):484-91. PubMed ID: 7866579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic CPEB4 and CPEB1 genes mutations spectrum on the prognostic predictive accuracy in patients with high-grade glioma and their clinical significance.
    Boustani MR; Mehrabi F; Yahaghi E; Khoshnood RJ; Shahmohammadi M; Darian EK; Goudarzi PK
    J Neurol Sci; 2016 Apr; 363():80-3. PubMed ID: 27000226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the issue of early and aggressive treatment in grade 2 gliomas.
    Ribom D; Smits A; Hartman M; Persson L; Blomquist E
    J Cancer Res Clin Oncol; 2003 Mar; 129(3):154-60. PubMed ID: 12712330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma.
    Tietze A; Mouridsen K; Lassen-Ramshad Y; Østergaard L
    PLoS One; 2015; 10(4):e0123044. PubMed ID: 25875182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epileptic seizures in diffuse low-grade gliomas in adults.
    Pallud J; Audureau E; Blonski M; Sanai N; Bauchet L; Fontaine D; Mandonnet E; Dezamis E; Psimaras D; Guyotat J; Peruzzi P; Page P; Gal B; Párraga E; Baron MH; Vlaicu M; Guillevin R; Devaux B; Duffau H; Taillandier L; Capelle L; Huberfeld G
    Brain; 2014 Feb; 137(Pt 2):449-62. PubMed ID: 24374407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recognition and management of gliomas.
    Kaba SE; Kyritsis AP
    Drugs; 1997 Feb; 53(2):235-44. PubMed ID: 9028743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profile as a prognostic factor in high-grade gliomas.
    Czernicki T; Zegarska J; Paczek L; Cukrowska B; Grajkowska W; Zajaczkowska A; Brudzewski K; Ulaczyk J; Marchel A
    Int J Oncol; 2007 Jan; 30(1):55-64. PubMed ID: 17143512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicentric gliomas: report of 2 cases.
    Pathak A; Sharma BS; Kak VK; Vasista RK; Banerjee AK
    Indian J Cancer; 1993 Dec; 30(4):205-8. PubMed ID: 8206505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gliomas in children: a review.
    Rilliet B; Vernet O
    Childs Nerv Syst; 2000 Nov; 16(10-11):735-41. PubMed ID: 11151725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
    Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
    NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management and outcome of high-grade multicentric gliomas: a contemporary single-institution series and review of the literature.
    di Russo P; Perrini P; Pasqualetti F; Meola A; Vannozzi R
    Acta Neurochir (Wien); 2013 Dec; 155(12):2245-51. PubMed ID: 24105045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade gliomas: in search of evidence-based treatment.
    Bernstein M
    Clin Neurosurg; 1997; 44():315-30. PubMed ID: 10080015
    [No Abstract]   [Full Text] [Related]  

  • 38. [Brain tumors. Mainly glial tumors in adults].
    Kosteljanetz M
    Ugeskr Laeger; 2002 Jun; 164(23):3017-20. PubMed ID: 12082850
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic relevance of MIB-1 immunoreactivity, S-phase fraction, 5-bromo-2'-deoxyuridine labeling indices, and mitotic figures in gliomas.
    Struikmans H; Rutgers DH; Jansen GH; Dullens HF; Oosten L; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1999; 7(4):243-8. PubMed ID: 10492165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Grade II gliomas-not so low grade.
    Shonka NA
    Oncology (Williston Park); 2014 Dec; 28(12):1016. PubMed ID: 25510801
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.